Data underlying the study's findings are available in the publicly accessible INDEPTH Data repository at <https://doi.org/10.7796/VADU.PSBI.2019.v1>.

Introduction {#sec005}
============

Globally 2.5 million neonatal deaths were documented in 2018, with Southern Asia having a neonatal mortality rate of 25 per 1000 live births \[[@pone.0236355.ref001]\]. Worldwide, neonatal sepsis, pneumonia and meningitis together result in up to 25% of all newborn deaths \[[@pone.0236355.ref002],[@pone.0236355.ref003]\]. Highest incidence of neonatal sepsis (17,000/ 1,00,000 live births) was reported from India \[[@pone.0236355.ref004]\]. The mean incidence of bacterial infection among neonates in South Asia is reported as 13.2% per 1000 livebirths and bacterial infections accounted for 92% of the known causes of death due to possible serious bacterial infections. \[[@pone.0236355.ref005]\].

World Health Organization (WHO) labels potential neonatal sepsis as possible serious bacterial infections (PSBI) in young infants (0--59 days) and recommends referral to a hospital for injectable antibiotics and supportive care. However, in resource-limited settings, especially tribal and geographically difficult terrains, such referrals are often not feasible \[[@pone.0236355.ref006]--[@pone.0236355.ref009]\], due to distance, cost or cultural reasons \[[@pone.0236355.ref010],[@pone.0236355.ref011]\]. Feasibility of treating severe infections in young infants in low resource settings on outpatient basis were first demonstrated in South-east Asia \[[@pone.0236355.ref006]--[@pone.0236355.ref009]\]. Subsequently, several large community based, randomized trials in Africa and Asia demonstrated the effectiveness of simplified antibiotic regimens in out-patient settings among young infants up to two months of age with signs of PSBI where referral was not feasible \[[@pone.0236355.ref012]--[@pone.0236355.ref016]\]. WHO in 2015 synthesized available evidence to develop global guidance for management of PSBI in young infants when referral is not feasible \[[@pone.0236355.ref017]\]. The Government of India also approved a policy for management of PSBI where referral is not possible with simplified antibiotic regimen by primary health care providers \[[@pone.0236355.ref018], [@pone.0236355.ref019]\].

However, implementation of such guideline in the public health system requires a multi-pronged approach and involves dialogue with the policy makers and program managers, understanding barriers and facilitators for implementation and providing technical support for implementation. While implementation challenges were well documented in controlled conditions in the above mention Asian and African countries, we could not find barriers to implementation of PSBI management within the public health system in India. Thus, an implementation research was planned across four different sites in India within the public health system to facilitate policy adoption and implementation of the WHO PSBI guideline. Maharashtra state has a relatively well functioning public health system and a private sector compared to many other states in India \[[@pone.0236355.ref020]\]. However, its tribal areas still have poor access to health care due to lack of proper roads, inadequate number of health facilities as well as low level of income and education among tribal population \[[@pone.0236355.ref021]\]. We describe here the process of implementation and outcomes of simplified management of PSBI in young infants in a tribal population from Western Maharashtra, India.

Methods {#sec006}
=======

Aims {#sec007}
----

The aims of the implementation strategy were:

-   To set up a demonstration site to deliver this intervention through policy dialogue and orientation meetings with Ministry of Health and other stakeholders at state and district level

-   To demonstrate the feasibility of delivering simplified antibiotic regimens to young infants with PSBI where referral is not possible within programme setting through partnership between programme implementers and researchers

Objectives {#sec008}
----------

1.  All first level health facilities will provide simplified outpatient management of PSBI when referral is not possible.

2.  At least 80% of identified sick young infants will receive treatment.

3.  At least 80% of the identified sick young infants will receive adequate treatment (Adequate treatment was considered as antibiotic doses for the first two days followed by at least 70% of doses over the next five days.)

Design {#sec009}
------

The study was part of a multi-site and multi-country mixed-methods implementation research coordinated by WHO to test the feasibility of implementing PSBI guidelines where referral is not feasible in a programme setting. The other countries supported by WHO in this study were Democratic Republic of Congo, Ethiopia, Malawi, Nigeria and Pakistan. The Pune site study involved a partnership between King Edward Memorial Hospital Research Centre (KEMHRC) Pune, a research institution and the public health system in Maharashtra state and specifically, Pune district. A common protocol and common tools were developed by the WHO team and used across four different sites in India. The guideline for management of PSBI in young infants, where referral is not feasible \[[@pone.0236355.ref018], [@pone.0236355.ref019], [@pone.0236355.ref022]\] constituted the study intervention while the implementation strategy included its introduction and implementation within the public health system in the study area. We have deliberately linked the intervention and the implementation strategy and not separated them while describing the study methods, as it reflects the actual 'real-world' conditions in which this study was conducted \[[@pone.0236355.ref023]\].

The Implementation strategy {#sec010}
---------------------------

### Study partners {#sec011}

The public health system, Pune district (implementation team), was responsible for implementing the study activities including identification and management of PSBI in young infants, ensuring effective referral systems and availability of medicines and equipment. The team from KEMHRC \[Research and support team (RST)\] was responsible for providing technical assistance, capacity development and supportive supervision to public health system workers as well as research data documentation. This clear division of responsibilities was a deliberate decision to ensure that the study could replicate programme conditions wherein the public health system is expected to implement the intervention with limited external assistance. [Fig 1](#pone.0236355.g001){ref-type="fig"} shows the study logic framework for this study in the form of inputs, activities and outcomes by both study partners.

![Logical framework for an implementation strategy for introducing PSBI management in young infants in the public health system, Pune.](pone.0236355.g001){#pone.0236355.g001}

### Policy dialogue for implementing adapted guidelines {#sec012}

A national level consultative meeting was held in 2016 to review, adopt and adapt the WHO guidelines for PSBI management which resulted in certain changes in the Indian IMNCI guideline ([S1 Table](#pone.0236355.s001){ref-type="supplementary-material"}). These changes included consolidation of signs and symptoms of PSBI based on which PSBI sub-classifications were modified and increased dose of oral amoxicillin was added. These changes were based on the evidence generated from the AFRINEST and SATT studies \[[@pone.0236355.ref013]--[@pone.0236355.ref016]\]. A policy decision was also made to adopt a regimen of seven-day injectable gentamicin and oral amoxicillin for PSBI when referral was not feasible \[[@pone.0236355.ref018],[@pone.0236355.ref019]\]. The meeting resulted in a consensus on adaptation and implementation in four demonstration sites in selected states in India.

A second orientation and policy dialogue was conducted at the Maharashtra State level in early 2017 by study investigators from KEMHRC to ensure the buy-in from local health authorities and decision makers including Additional Director Health Services, State of Maharashtra (ADHS) and the District Health Officer (DHO), Pune. The public health system agreed to be a partner in the study and selection of the study area was decided at this meeting. This dialogue resulted in the establishment of a Technical Support Unit (TSU). The TSU was an independent oversight body which comprised of senior public health officials from public health system, a paediatrician of government medical college and the investigators representing the RST. The role of the TSU was to provide guidance and leadership to the project and review the progress of the project and provide suggestions to challenges arising during the study conduct.

Ethical considerations {#sec013}
----------------------

The study was initiated after obtaining approval from KEMHRC and the WHO research ethics review committee. The study was implemented following good clinical practices and Indian Council of Medical Research guidelines for research involving human participants.

Study area {#sec014}
----------

The study was conducted across eight tribal Primary Health Centres (PHCs) situated in three blocks of Pune district namely Junnar, Ambegaon and Khed ([Fig 2](#pone.0236355.g002){ref-type="fig"}). All the selected villages in the study area were located in geographically difficult-to-access terrains but had public health infrastructure available for implementation. These PHCs are located in the Western Ghats of Maharashtra, covering total 1,40,000 population. Each PHC catered to around 20,000 population and comprised of 5--12 sub-centres (SC) serving about 3,000 population each. Details about the health infrastructure are presented in [S2 Table](#pone.0236355.s002){ref-type="supplementary-material"} and [Fig 3](#pone.0236355.g003){ref-type="fig"}.

![Map of the study area in Pune district.](pone.0236355.g002){#pone.0236355.g002}

![Health infrastructure of the study area.](pone.0236355.g003){#pone.0236355.g003}

Baseline survey and mapping of referral system {#sec015}
----------------------------------------------

A baseline survey was conducted by the RST in the eight selected PHCs and 15 randomly selected health sub-centres within these PHCs in order to asses readiness of facilities to implement the PSBI guidelines. This included review and availability of staff, knowledge, training and practice of auxiliary nurse midwives (ANMs), equipment, medicines, consumables and reporting systems relevant to PSBI management. The survey also included semi-structured interviews administered to 62 Accredited Social Health Activists (ASHA) and 121 mothers of young infants to understand their knowledge and practices related to care of young infants \[Supplement\]. Additionally, mapping was done of public as well as private health facilities with Neonatal Intensive Care Units (NICU)/ Special Newborn Care Units (SNCU) in increasing order of distance from the PHCs. The availability of ambulances in working conditions and the existing process of referrals were also documented.

Trainings and orientation {#sec016}
-------------------------

Officials from the public health system and a member of the RST were trained as "master trainers" by trainers from WHO and IMNCI program of India in an extensive three-day training on assessment, classification and management of PSBI along with newborn care. The training included interactive class room training as well as hands on clinical practice. The algorithm for identification and management of PSBI was prepared from adopting updates from the WHO PSBI guideline on managing PSBI in young infants when referral is not feasible \[[@pone.0236355.ref017]\] to the WHO young infant IMCI chart booklet, 2019 \[[@pone.0236355.ref022]\]. Although the WHO young infant IMCI chart booklet was printed in 2019, the draft was used to adapt the Indian guideline to manage PSBI when referral was not feasible. The master trainers then used the same training methods and materials to train all medical officers (MO) and ANMs in the study area. The MOs with support from RST, oriented ASHAs on identifying danger signs of PSBI and essential newborn care, at their respective PHCs. Twelve MOs, 68 ANMs and 265 ASHAs in the eight selected PHCs were trained through these sessions.

The Intervention {#sec017}
================

Implementation of simplified management of sick young infants ([Fig 4](#pone.0236355.g004){ref-type="fig"}) {#sec018}
-----------------------------------------------------------------------------------------------------------

![Flow chart of PSBI identification and management.](pone.0236355.g004){#pone.0236355.g004}

### i. Identification of sick young infants {#sec019}

The ANMs, as part of their routine activities recorded all pregnancies and births in their coverage area and ASHAs visited all neonates on days 1, 3, 7, 14, 30 and 42 of birth as per national guidelines. During these visits, ASHAs counselled the caregivers about danger signs of PSBI in addition to providing newborn care and identifying danger signs of illness if they came across a sick young infant. Young infants with axillary temperature 37.5°C or above, axillary temperature less than 35.5°C, fast breathing, chest indrawing, convulsions, difficulty in feeding or reduced movements were then brought to ANMs or MOs for further assessment and intervention. At PHC/SC level, the sick young infants were assessed by MOs or ANMs for signs of PSBI and referred to Civil hospital, the tertiary care centre in our study, if needed. The sick young infants were classified as either PSBI, with sub-classifications of clinical severe infection (CSI), critical illness (CI) and fast breathing (FB) in 0--6 days old infants, or FB in 7--59 days old infants.

### ii. Referral to tertiary health care facilities {#sec020}

As per guidelines, caregivers of young infants classified as CSI, CI or FB (only in 0--6 days old) were counselled about the need for hospitalization and were advised referral by MOs and ANMs to the civil Hospital the for treatment. The rural hospitals and sub-district hospitals only manage uncomplicated infection cases in infants, provide immediate post-natal care but do not have neonatal intensive care facilities to manage serious illness. Hence these were not considered as referral facilities for PSBI cases. In many cases, ASHAs accompanied the young infants to the tertiary care. Such young infants were given first dose of gentamicin intramuscularly before referral to tertiary health care facilities. For every referral, a referral slip was handed over to the parent to show to the tertiary care facility. The caregivers were given instructions to maintain warmth and provide breastfeeding to the baby during transportation. In infants classified as CI, CSI or FB (only in 0--6 days old), whenever the referral was not feasible, MO/ANM continued to provide care as per adapted PSBI management algorithm \[[@pone.0236355.ref022]\].

### iii. Treatment when referral is not feasible or referral is not recommended {#sec021}

When referral was not feasible, even after making all efforts to counsel and refer, infants aged 0--6 days with FB and young infants with any sign of CSI were treated with a course of intramuscular gentamicin 5--7.5 mg/kg once daily for 7 days and oral amoxicillin 50mg/kg twice daily for 7 days on an outpatient basis. Infants with CI were started on a course of intramuscular ampicillin and intramuscular gentamicin daily for seven days. The MOs had overall responsibility for identification of PSBI, choosing the appropriate treatment and administering the treatment. All doses of injection gentamicin and first daily dose of oral amoxicillin were administered by the MO or ANM in consultation with the MO at the PHC and the second oral amoxicillin dose for the day was administered by mother after being taught to ascertain the correct dose and method of administration by ANM. All young infants aged 7--59 days with FB were treated with oral amoxicillin 50mg/kg twice daily for 7 days as per the treatment algorithm \[[@pone.0236355.ref022]\]. Caregivers were taught to administer oral amoxicillin at home, counselled on identifying signs of deterioration and were asked to bring the infant back to the ANM if there was any such sign. If the child\`s health would deteriorate, they were again advised referral. The protocol defined adequate treatment as antibiotic doses for the first two days followed by at least 70% of doses over the next five days.

### iv. Monitoring and follow up {#sec022}

Young infants with any sign of CSI or CI, or FB (only in 0--6 days old infants) who received outpatient treatment were followed up every day till day 7 of treatment. Infants aged 7--59 days with only FB who received oral amoxicillin were followed up on the 4^th^ and 8^th^ days of starting treatment by ASHA/ANMs to assess the infant's condition and adherence to treatment, while if they were treated at private health facilities, follow-up was done on the 8^th^ day only. In case of referred sick young infants, first telephonic follow up was done by ANM during hospitalisation and second follow up was done at home by ANM with ASHA after hospital discharge within 14 days of onset. All clinical assessments, identification and management of PSBI by ANMs and MOs were recorded in IMNCI forms at PHCs ([Fig 4](#pone.0236355.g004){ref-type="fig"}).

Activities of the KEMHRC RST {#sec023}
----------------------------

The RST, in consultation with the Implementation team developed the study protocol and study tools. It organized and conducted training for all health workers in the study area. The RST did not participate in any implementation activities but was available for on-field support to the health care workers and whenever needed provided additional training related to assessment, classification and management of PSBI cases. Study activities were jointly supervised by members of the RST and senior district level public health authorities. RST members were consulted by MOs/ANMs regarding identification of PSBI and use of the treatment algorithms for appropriate management, in approximately 10% of all PSBI cases managed. The consultations were done as and when required and there was no pre-decided pattern. The RST coordinated with the block and district level authorities to solve challenges and problems in the field. The RST transcribed data related to PSBI case management from records maintained by healthcare workers onto case record forms developed for this study. Finally, the RST was responsible for analysis and presentation of results from this study.

Communication {#sec024}
-------------

Based on the results of the baseline survey, information, education and communication tools were developed by the RST with inputs from the health workers. This consisted of charts and booklets depicting signs and symptoms of PSBI and their management as per adapted study guidelines when the referral is not feasible. The RST communicated with the Implementation team during their weekly meetings at the respective PHCs in addition to the frequent face to face and telephonic interactions during and after identification of the suspected PSBI cases. The RST and Implementation team also used multimedia technology like WhatsApp videos to confirm the signs in five to six young infants with suspected PSBI. In addition, there were regular meetings with block and district level authorities to discuss the challenges faced and devise solutions to overcome these. These meetings were held once every month for the initial five-six months as most of the challenges were identified during these initial months into the study and thereafter, once every three months. These helped in devising solutions to improve case identification, ensuring uninterrupted supplies of medicines and consumables and ensuring referral mechanisms could function appropriately.

Data management and analysis {#sec025}
----------------------------

The data were entered into electronic record forms created using REDcap software. The data management was done on local standalone server with back up facilities. Anonymized dataset was extracted and was used for analysis for quality control. Descriptive analysis was done using Microsoft Excel calculations of frequencies and proportions.

Study period {#sec026}
------------

The baseline and preparatory activities were conducted between March 2017 and July 2017 while field activities were conducted between August 2017 and March 2019.

Results {#sec027}
=======

Preparatory phase {#sec028}
-----------------

### Baseline survey {#sec029}

The baseline survey of the facilities in the study area showed that all the eight PHCs and 64 SCs in the study area were functional in terms of availability of human resources, medicines and supplies, updated documentation and patient flow. There were three 30-bedded rural hospitals (one in each block) located within 20--40 km distance from each PHC whereas a 100-bedded subdistrict hospital was located at 70--80 km from the PHCs ([Fig 3](#pone.0236355.g003){ref-type="fig"}). There were approximately 8--10 private health facilities within the study area, with 2--3 having intensive care units. All PHCs were equipped with one ambulance each for referral to a higher health facility. However, vehicles were not available at all times and patients sometimes needed to spend money for fuel or arrange for alternate transport to reach a higher health facility. There were adequate human resources working at the eight PHCs. The details of the staff and population catered for the eight PHCs in given in [S2 Table](#pone.0236355.s002){ref-type="supplementary-material"}.

We found that 95% ASHAs reportedly conducted home visits post-delivery as per government guidelines and about 80--85% ASHAs were aware about overall care of young infants and counselling for newborn care. Amongst the caregivers, 90% mothers had received counselling on care of young infants post-delivery. However, only 55--60% ASHAs on an average, were aware of danger signs in young infants and only 50% of the mothers on average received counselling on the same. MOs and ANMs had been trained in IMNCI. Before initiation of this project, none of the ANMs and MOs reported to have identified and managed PSBI in young infants in the past three months. Sick young infants approaching the PHCs were routinely referred to higher-level health facilities by the MOs. A crucial reason cited was lack of confidence and fear of mishap in handling sick young infants at a peripheral health facility. However, they showed readiness to manage cases with PSBI if they were provided with appropriate training and technical support. This survey also revealed that caregivers of young infants from the tribal population generally did not show readiness for accepting referral and preferred home-based care due to cultural and socioeconomic reasons (lack of belief in healthcare, non-affordability, unavailability of transport, loss of wages). Most of the ANMs were not experienced in administration of intramuscular gentamicin in infants. Most of the PHCs were equipped with baby warmer but were not adequately equipped with weighing scales, thermometers and stopwatches or timers to count respiratory rate. Oral amoxicillin was not available at all centres at the time of the survey, whereas injectable gentamicin vials in a dose of 80mg/2ml and syringes for intramuscular administration were available.

### Discussion at State and district level for assurance of supplies {#sec030}

Observations from the baseline assessment were communicated by RST to the senior officials from the public health system in face to face meetings. Assurance for support was obtained from the government officials in order to maintain the health staff and adequate supplies of amoxicillin, gentamicin and consumables. Before implementation, the PHCs and SCs were strengthened by the RST with provision of weighing scales, thermometers and stopwatches/timers for counting respiratory rate to all ASHAs.

Implementation phase {#sec031}
--------------------

### Birth surveillance and postnatal visits {#sec032}

During the study period, total 3071 live births were recorded from all the institutions. Of these, 2001 (65%) could be followed up for post-natal home-based care by ASHAs. Post-natal home visits were made by ASHAs in majority of the cases ([S3 Table](#pone.0236355.s003){ref-type="supplementary-material"}). A decrease from the first post-natal visit in subsequent postnatal visits were due to parents moving out of study area after discharge from the health facility and lack of documentation by the ASHAs for some of the visits.

### Identification and management of sick young infants {#sec033}

A total 545 sick young infants were assessed during the study implementation phase, of which 175 had signs of PSBI (34 CI, 46 CSI, 10 FB in 0--6 days old infants and 85 infants aged 7--59 days with FB). ([Table 1](#pone.0236355.t001){ref-type="table"}). Assuming a 10% incidence (5, 13, 14, 15, 16) of PSBI among all live births, with 3071 live births recorded, the expected number of young infants with any sign of PSBI would be 307. We identified and treated 175 young infants with PSBI indicating actual coverage of 57%.

10.1371/journal.pone.0236355.t001

###### Identification of sick young infants during study duration (August 2017 to March 2019) in Pune.

![](pone.0236355.t001){#pone.0236355.t001g}

  Parameters                                                                              All sick young infants (N = 175)   Critical illness (CI) (N = 34)   Clinical severe infection (CSI) (N = 46)   Fast breathing (FB) in 0--6 days (N = 10)   Fast breathing (FB) in 7--59 days (N = 85)
  --------------------------------------------------------------------------------------- ---------------------------------- -------------------------------- ------------------------------------------ ------------------------------------------- --------------------------------------------
  Brought by families to PHC/SC, n (%)                                                    67 (38.3)                          5 (14.7)                         20 (43.5)                                  4(40.0)                                     38 (44.7)
  Identified by ASHAs in the community and referred to PHC/SC, n (%)                      62 (35.4)                          11 (32.3)                        15 (32.6)                                  1(10.0)                                     35 (41.2)
  Identified at PHC/SC by ANM/MO following birth or during immunisation sessions, n (%)   46 (26.3)                          18 (52.9)                        11 (23.9)                                  5(50.0)                                     12 (14.1)

PHC- Primary health centre, SC- subcentre, ANM- Auxiliary nurse midwife, MO- medical officer,

### Identification of illness {#sec034}

About 38.3% PSBI cases were identified by the families, 35.4% by ASHAs and the rest were identified by MO/ANMs.

### Referral to government or private tertiary care and management of sick young infant at PHC/SC ([Table 2](#pone.0236355.t002){ref-type="table"}) {#sec035}

10.1371/journal.pone.0236355.t002

###### Referral, treatment and outcome of sick young infants during study duration.

![](pone.0236355.t002){#pone.0236355.t002g}

  Parameters                                                                                  All infection cases (N = 175)   Critical illness (CI) (N = 34)   Clinical severe infection (N = 46)   Fast breathing in 0--6 days (N = 10)   Fast breathing in 7--59 days (N = 85)
  ------------------------------------------------------------------------------------------- ------------------------------- -------------------------------- ------------------------------------ -------------------------------------- ---------------------------------------
  **Referral and treatment of sick young infants, n (%)**                                                                                                                                                                                  
  Referral to tertiary government facility accepted                                           48 (27.4)                       27 (79.4)                        17 (37.0)                            4(40.0)                                
  Referral was accepted but went to private facility                                          55 (31.4)                       06 (17.6)                        24 (52.2)                            3(30.0)                                
  Referral not possible and treated at PHC/SC                                                 9 (5.1)                         1 (2.9)                          5 (10.9)                             3(30.0)                                
  Referral not recommended and treated at PHC/SC                                              62(35.4)                        \-\--                            \-\--                                \-\--                                  
  Refused referral and also refused treatment at PHC/SC                                       \-\--                                                            \-\--                                \-\--                                  
  **Follow up of all sick young infants, n (%)**                                                                                                                                                                                           
  Completion of at least one follow-up visit by ANM [^\#^](#t002fn001){ref-type="table-fn"}   174 (99.4)                      34 (100.0)                       46 (100.0)                           10(100.0)                              84 (98.8)
  **Final treatment outcomes, n (%)**                                                                                                                                                                                                      
  Clinical treatment success^\$^                                                              168 (96.0)                      33 (97.1)                        41 (89.1)                            10 (100.0)                             84 (98.8)
  Death                                                                                       6 (3.4)                         1 (2.9)                          5 (10.9)                             0 (0.0)                                0 (0.0)
  Outcome unknown                                                                             1 (0.6)                         0 (0.0)                          0 (0.0)                              0 (0.0)                                1 (1.2)

^\#^---follow up was completed within 8 days for sick young infants treated at PHC and telephonic follow up for infants referred and hospitalised at tertiary centre/private facility followed by home visits by ANM after discharge; WHO guideline recommends Day 4 mandatory follow-up; \$---The treatments include treatments given at the tertiary referral as well as simplified regimens offered at PHC/SC.

Among the 90 PSBI cases that were eligible for referral and were advised referral to a government tertiary care centre, 81 (90%) accepted referral. Among 81 young infants with any sign of PSBI who accepted referral, 48 (59.3%) were hospitalized at a government tertiary care, while 33 (40.7%) preferred to visit a private facility. Pre-referral doses of gentamicin were given in only 7.1% (6 out of 84) of the cases. Those who refused referral (n = 9) received simplified antibiotic treatment on outpatient basis at PHC/SC level, of which five were classified as CSI, three as fast breathing in infants aged 0--6 days and one had CI. All 85 cases of FB infants aged 7--59 days were offered treatment at PHCs, 62 (72.9%) infants accepted and were treated with oral amoxicillin, while 22 (25.9%) infants refused treatment and went to a private facility. One case of FB in 7--59 days old infant, refused treatment with oral amoxicillin as the parents immediately migrated out of the study area; this case could not be followed up for outcome. We could not collect treatment information on treatment given from private health facilities.

### Clinical outcomes in sick young infants ([Table 2](#pone.0236355.t002){ref-type="table"}) {#sec036}

Of 175 infants, 168 (96%) were cured of their illness, with similar cure rates at public and private healthcare centres. Six (3.43%) young infants with PSBI (five CSI and one CI) died. All these infants were very low birth weight (average birth weight 1.4 ± 0.21 kg) and pre-term (less than 34 weeks gestational age) and all were diagnosed with signs of PSBI on day 0 or 1 of life. All the six infants were referred to the district hospital but only four accepted the referral (including one self-referral to private health care). Two infants refused referral and were started treatment at the PHC on day-1 of identification. One received two doses of oral amoxicillin and no injection gentamicin and the other received three days treatment with injection gentamicin and oral amoxicillin. Both were discharged against medical advice and subsequent deaths (on day three and six respectively) were reported by ASHAs following home visits. Among infants aged 7--59 days with FB, treatment success was 100%, irrespective of the place of treatment.

### Treatments given to sick young infants when referral was not recommended or possible ([Table 3](#pone.0236355.t003){ref-type="table"}) {#sec037}

10.1371/journal.pone.0236355.t003

###### Treatment for sick young infants when referral was not recommended or feasible.

![](pone.0236355.t003){#pone.0236355.t003g}

  Parameters                                                            All PSBI cases (N = 9)   Critical illness (CI) (N = 1)   Clinical severe infection (N = 5)   Fast breathing in 0--6 days (n = 3)   Fast breathing in 7--59 days (n = 62)
  --------------------------------------------------------------------- ------------------------ ------------------------------- ----------------------------------- ------------------------------------- ---------------------------------------
  **Intramuscular gentamicin doses (5--7.5 mg/kg once daily), n (%)**                                                                                                                                      
  Received all 7 injections                                             6 (66.7)                 1 (100.0)                       2 (40.00)                           3(100.0)                              
  Received 3 injections                                                 1 (11.1)                 0 (0.0)                         1 (20.0)                            0(0.0)                                
  Received 1 injections                                                 0(0)                     0(0.0)                          0 (0.0)                             0(0.0)                                
  Received no injection[^\#^](#t003fn002){ref-type="table-fn"}          2(22.2)                  \--                             2(40.0)                             \--                                   
  **Oral Amoxicillin doses (50mg/kg twice daily), n (%)**                                                                                                                                                  
  Received all 14 doses of treatment                                    61(84.7)                 1(100.0)                        2(40.0)                             3(100.0)                              55(88.7)
  Received 10--13 doses of treatment                                    5 (6.9)                  00(0.0)                         0(0.0)                              0(0.0)                                5(8)
  Received 6--9 doses of treatment                                      1 (1.4)                  0(0.0)                          0(0.0)                              0(0.0)                                1(1.61)
  Received ≤5 doses of treatment                                        4 (5.6)                  0(0.0)                          2(40.0)                             0(0.0)                                1(1.61)
  Received no amoxicillin[^\#^](#t003fn002){ref-type="table-fn"}        1 (1.4)                  \--                             1(20.0)                             \--                                   0(0.0)

The protocol defined adequate treatment as antibiotic doses for the first two days followed by at least 70% of doses over the next five days.

^\#^ The infant did not receive any treatment as body weight was less than 1.5 kg;

Nine sick infants with PSBI (5 CSI, 1 CI, 3 FB in 0--6 days old infants) for whom referral was not possible, received simplified regimen at PHC/SC. Six (67%) of these cases received complete treatment with gentamicin and oral amoxicillin, one sick young infant with CSI received three injections of gentamicin and three days of oral amoxicillin and one received two doses of oral amoxicillin and no injection gentamicin. One infant did not receive any treatment as its weight was 1.4 kg and MOs/ANMs of that particular PHC refused to treat such very low birth weight babies. Since its parents refused referral, the infant was offered Kangaroo mother care and closely followed up and went on to recover from the illness. This infant had hypothermia and movements were lesser than normal. Breastfeeding was initiated and continued adequately.

Of the 85 cases of FB in 7--59 days infants, 62 infants aged 7--59 days with FB pneumonia received treatment at PHC/SC. Of these, 55 (88.7%) completed treatment with oral amoxicillin and 7 (11.2%) infants received less than adequate treatment for 6--13 days. The remaining 22 infants who took treatment from private facilities were followed up on the 8^th^ day of the illness and were found to be cured. One case was lost to follow-up.

Study progress and facilitators and challenges for implementation {#sec038}
-----------------------------------------------------------------

The number of cases managed in the first five months were less than expected, with few health staff identifying and managing PSBI cases. The RST provided on-field support to all health staff while public health officials, through their feedback mechanisms, encouraged health staff to identify and manage PSBI cases. With these efforts, case reporting did increase over the remaining 15 months of the study period ([Fig 5](#pone.0236355.g005){ref-type="fig"}).

![Progression of identification of sick young infants with PSBI.](pone.0236355.g005){#pone.0236355.g005}

### Facilitators for success {#sec039}

The ownership of the study by the public health officials at the state and district levels and establishment of TSU were major facilitators that contributed to a smooth implementation of the study. This buy-in of the public health system was a crucial aspect of this implementation research study in terms of potential sustainability and scale-up.

Training sessions for all health staff in the study areas played a major role in enhancing the knowledge and capacity building of MOs, ANMs and ASHAs in identification and management of the PSBI cases. This also provided opportunity for trainers to allay their apprehension and lack of confidence about handling sick young infants. Study-related communication at all levels in public health system increased awareness about the PSBI and importance of treatment and timely referral in these cases among the Implementation team. This helped the Implementation team in prioritising management of sick young infants through simplified regimes and increased their ownership towards the program. These was evident from the change in practices regarding managing PSBI in young infants, with the baseline survey showing that no PSBI case was managed at PHCs prior to the study implementation.

A robust and effective referral system ensured that a majority \[81 out of 90 (90%)\] of young infants with PSBI, who were eligible for referral to government tertiary care health centres, actually accepted referral to such centres. The role of ASHAs was specifically important in persuading the caregivers to accept the referrals. In some cases, ASHAs, being the member of the same community, with help from the local community leaders and village heads also arranged for logistics or monetary support from within the village for transport of the sick young infants to health care facility when ambulance was not available immediately.

### Challenges faced {#sec040}

Our study faced various challenges and barriers during implementation, which resulted in numerous modifications of the predefined protocol ([Table 4](#pone.0236355.t004){ref-type="table"}).

10.1371/journal.pone.0236355.t004

###### Challenges face during implementation research, steps taken and end result.

![](pone.0236355.t004){#pone.0236355.t004g}

  No                                                                           Issue                                                                                                                                                                                                                                                                              Steps taken                                                                                                                                                                                                      End result
  ---------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  1                                                                            Inadequate case reporting in the first six months and lack of coordination between ASHAs and ANMs                                                                                                                                                                                  Re orientation of ANM and ASHAs in identifying PSBI                                                                                                                                                              Increased case reporting in next 15 months period of the study. However, few ASHAs and ANMs still reported fewer cases/population than others
  Counselling of ANMs by MOs to increase case-finding efforts                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  On-field support for low-performing ASHAs and ANMs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  2                                                                            Documentation by ANMs/MOs                                                                                                                                                                                                                                                          Re-orientation sessions and hand-holding for recording complete data for individual cases.                                                                                                                       Most ANMs recorded adequately; ANMs in busier PHCs complained of lack of adequate time to fill in IMNCI forms completely
  3                                                                            Parents taking their sick Young infants to private providers in-spite of advice for referral to government tertiary care centres. Primary reasons given for private preference were relatively more confidence in and relative ease of negotiating private health-care processes   MOs and ANMs counselled parents for referral to government tertiary care centers                                                                                                                                 Referrals to Government facilities improved over the study period, but few parents still preferred private providers
  4                                                                            A smaller proportion of PSBI cases received pre-referral doses.                                                                                                                                                                                                                    MOs/ANMs supported in administering pre-referral Gentamicin injections                                                                                                                                           The number improved, but only 6 PSBI cases received pre-referral doses in the study.
  5                                                                            Unavailability of ambulance service needed for prompt transport of sick young infant to referral centre                                                                                                                                                                            ASHAs and ANMs coordinated with the village heads for making a vehicle available for the patient.                                                                                                                The sick young infant got access to treatment at tertiary care centre.
  District health authorities ensured availability of ambulance at all PHCs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  6                                                                            Unavailability of antibiotics in some PHC/SCs in the first three months of the study.                                                                                                                                                                                              The RST coordinated between different health facilities to make the supplies available to the ones which did not have enough supply. District health authorities ensured availability of medicines at all PHCs   The antibiotics were subsequently made available through the study period
  7                                                                            Lack of experience in administration of gentamicin injection in low birth weight infants in the initial months of the study.                                                                                                                                                       Retraining and confidence building was done by the RST. MO/ANMs were trained in administering injections even to VLBW babies as part of routine immunizations                                                    The MO/ANM did not administer the prereferral dose in spite of the trainings as they were afraid of being responsible in case of mishap

Discussion {#sec041}
==========

Broadly speaking, this implementation research shows that it is feasible to implement the strategy of early identification, timely referral and simplified management of sick young infants in the public health system in tribal areas of Maharashtra. The public health system has successful managed 90% of the PSBI cases identified during the study period independently while 10% required consultation with the RST implying the study was implemented as planned.

We had reasonable treatment coverage of approximately 60% in our study. Similar implementation research studies on PSBI in young infants from African and Asian countries reported variable treatment coverages of 16.3% in Sylhet and Chittagong in Bangladesh \[[@pone.0236355.ref024]\], 50% in Ethiopia \[[@pone.0236355.ref025]\], 42% in Kushtia district, Bangladesh \[[@pone.0236355.ref026]\], 63.8% in Malawi \[[@pone.0236355.ref027]\] and 95% in Nigeria \[[@pone.0236355.ref028]\]. Thus, except for the Nigeria study, our coverage proportions were comparable with other reported coverages. However, our coverage could have been higher; a major factor in our study area was the preference of private health facilities which might explain where the remaining estimated 40% cases of PSBI would have been managed. Another factor could be that some PSBI cases visited the sub-district and district hospitals directly. However, we did not collect data from these hospitals as this was outside the study protocol. We estimate that the actual coverage may need a correction factor. The coverage achieved in our study was a result of effective and timely coordination between different facilities and cadre of the public health system. Ownership of the program and supervision by senior public health officials were crucial for achieving these coverage proportions. Along with it, support from the KEMHRC RST, especially in the early phase of the study played an important role in this. The processes conducted in our study can again inform the successful adoption of these guidelines in other districts and states in India, subject to local modifications.

One of the most important outcomes of this study was that fast breathing pneumonia in 7--59 days young infants was effectively and safely treated with oral amoxicillin on an out-patient basis without referral in a programme setting. Almost three-fourth of such infants were successfully treated by MOs/ANMs and were completely cured, with most receiving adequate doses of oral amoxicillin. The rest preferred private healthcare centres where they could have received treatment with other antibiotics and were also completely cured. MO/ANMs were able to ascertain preference for private facilities only after these cases came to SC/PHC and were diagnosed with PSBI. There was no scope in the study for separate data collection from those who directly went to private facilities. Primary reasons given for private preference were relatively more confidence in and relative ease of negotiating private health-care processes. In fact, this finding from the study will help to inform policy regarding PSBI management when referral is not feasible to a larger public sector hospital, wherein greater public-private partnership in health can be a recommendation to reduce infant mortality. However, from studies on antibiotic prescriptions, it has been seen that very few private facilities treat infections in children with simplified antibiotics such as gentamicin and amoxicillin, with most preferring higher-level antibiotics \[[@pone.0236355.ref029], [@pone.0236355.ref030]\]. In addition, affordability of such facilities remains a challenge, especially for the tribal communities as in the study area. Thus, a balanced view about the appropriateness, affordability as well as accessibility of private health facilities needs to be considered. In any case, this finding enables the public health system to effectively triage such cases and avoid referring them unnecessarily to tertiary care centres, thus reducing the workload at these centres as well as reducing the exposure of these young infants to higher-level anti-microbials. In the Malawi study, out of 150 young infants with FB, cure rate was achieved in 96% infants \[[@pone.0236355.ref027]\]. The study in Kushtia, Bangladesh reported that among 475 young infants with FB, approximately 80% of caregivers reported that their infant had received oral amoxicillin for five days and 74% for seven days and the treatment failure rate was approximately 5% \[[@pone.0236355.ref026]\]. Similar proportions were reported in the Nigeria study with All 7--59 days old young infants with fast breathing who received treatment at the outpatient improved with oral amoxicillin \[[@pone.0236355.ref028]\]. Thus, our study results had comparative results for outcomes of FB in 7--59 days infants, though, our numbers were lesser. Thus, it is feasible to enact this recommendation within the public health system in India.

The current Government of India guideline \[[@pone.0236355.ref018]\] recommends treatment by injectable gentamicin and oral amoxicillin for fast-breathing pneumonia in young infants aged 7--59 days. Our study data can help to inform the guidelines for necessary revision.

A relatively low case fatality rate of 3.4% (six deaths out of 175 cases) showed that the adapted PSBI guidelines can help reduce neonatal and infant mortality, if implemented appropriately by the public health system. However, considering the relatively low number of PSBI cases, we need to interpret this fatality rate with caution when applying to other areas as well as while scaling-up the intervention.

A striking finding from our study was the high acceptance (90%) of referral to tertiary care centres among eligible infants with PSBI. While all eligible PSBI infants were advised referral to government tertiary care centres, a substantial proportion preferred to visit a private tertiary care. The high number of referrals to government tertiary care hospitals was due to presence of effective communication amongst the care-providers and increased awareness and an effective referral system. Further, linkages with the tertiary government healthcare centres, facilitated through senior state level health officials, helped in successful referrals. While not assessed in details, on interviewing some parents, we found that the major reason for going to private facilities was easy acceptability, familiarity with the private physicians and proximity of the private facility as compared to a public facility. We thus recommend encouraging partnership between the public and private sector for healthcare delivery and implementing the guidelines for PSBI management, considering that one third of sick infants were managed at the private healthcare facilities were perceived to be more accessible to the general population than government tertiary care unit. This relates to our study area where private health facilities are available. Healthcare-seeking is a choice and it was clear from our study that a sizeable proportion preferred private facilities. Thus, in a population where there is some preference for private health facilities, it would be beneficial for the population if a private-public partnership with common treatment protocols is built, as there would be a choice for seeking care. This is applicable for many parts of India, wherein private facilities account for 60% of all outpatient visits and 40% of all inpatient admissions. However, quality, cost and completeness of treatment in private care remain a challenge. This aspect needs further investigation and we agree that the private health sector, where available, can play a valuable role in managing sick young infants. Our referral refusal proportion differs considerably from other similar studies, with referral refusal as high as 83% in Bangladesh, 90% in Malawi and 97% in Nigeria {24, 27, 28\]. The high acceptance of referral in our study could limit generalizability of this study to settings where such high referral is not possible.

Only about 10% of the PSBI cases who were recommended referral, refused referral and were administered simplified management at PHC/SC level. The common reasons for refusal of referral were lack of manpower and family support, financial issues and lack of transportation of facilities. We need to further explore ways to facilitate referrals for such cases, since the recommended guidelines for PSBI cases is treatment at a tertiary care facility. The quality of treatment received at PHC level was appropriate for two-thirds of the CSI, CI and FB in 0--7 days PSBI cases in those who accepted the treatment. While this was based on only 9 cases for which referral was not possible, of which quality treatment was given to 6 cases, we admit that even for such a small number, the quality should have been higher and is a limitation in our study. The one infant with a birth weight of 1.4 kg and not given any treatment, had hypothermia, which could be environmental and not due to PSBI. This infant was feeding well and was closely monitored till recovery.

An important finding from this study was the relative safety of the interventions as well as the implementation strategy, with none of the patients reporting adverse events. However, one limitation in our study is that we can only comment about safety of amoxicillin in FB in 7--59 days infants with confidence.

The most crucial factor for successful implementation was the complete ownership by the public health system, especially at the state level. The involvement of senior leadership in the public health system also ensures that the intervention can be scaled-up to other parts of the district and the state and can possibly be sustained in the form of a programme, though further policy-related dialogues are needed for this. Secondly, technical support to the public health system for an initial period of time helps to resolve many issues and streamline the implementation process.

Readiness of the public health system {#sec042}
-------------------------------------

We found that all health staff, including MOs, ANMs and ASHAs needed re-training in IMNCI including PSBI management. There were no major challenges regarding availability of medicines and consumables, however, equipment such as accurate weighing machines, stopwatches/respiratory rate timers needed for managing PSBI was inadequate. The equipment was made available after informing the district authorities. These issues, though can be relatively easily resolved within the public health system, by timely and appropriate communication need to be assessed before commencing implementation.

Acceptability and implementation penetration {#sec043}
--------------------------------------------

Within the public health system, the study strategy was generally well accepted. However, our study showed that initially, facilitation and hand-holding for a limited time, built confidence of entire public health system; especially the primary healthcare workers. This was reflected in an increase in the number of cases identified and managed after as the study progressed. However, the hesitancy of ANMs to administer pre-referral injectable gentamicin in young infants due to fear of adverse effects could not be overcome sufficiently in spite of refresher training and constant on-field support. The awareness about management of sick young infants and feeling of responsibility increased amongst Implementation Team, due to which the MOs/ANMs who did not manage a single sick infant with PSBI at baseline, could effectively manage sick infants at PHC/SCs when referral was not feasible. The acceptance amongst public health system and top-down communication was found to be a major facilitator.

Fidelity and system adaptations required {#sec044}
----------------------------------------

In PSBI cases, with 90% young infants successfully referred, though only a little over half accepted referral to government tertiary facilities as recommended, we can say that fidelity, in terms of referral to government tertiary facilities, was not achieved as expected. However, this was probably driven by the prevalent care-seeking preferences in the study population and needs to be explored further., while, among those not referred, further efforts need to be taken to ensure that all such infants are adequately treated on an out-patient basis. These efforts could include more effective counselling of care-givers, greater involvement of local community leaders in counselling efforts and more support from senior public health officials. No major system adaptations were required. However, a limitation of this study was the low proportion of pre-referral injectable gentamicin in this study indicating that there is a need for motivation and confidence-building, including support of senior public health authorities, of MOs, ANMs and ASHAs to administer pre-referral gentamicin.

This implementation science research was appreciated by the public health system and in future, the RST was invited to continue working with the public health system. The TSU and the public health system is keen to scale up these adapted PSBI guidelines to entire state of Maharashtra. This will be done by scaling up the training activities and awareness program through the district training teams in the state. However, in order to make the program sustainable, it is important that the role of RST is taken over by the public health system and TSU.

Conclusion {#sec045}
==========

The study demonstrated that the identification and management of PSBI in young infants can be implemented at out-patient facilities in the public health system. Fast breathing in 7--59 days old can be effectively managed with oral antibiotic on an outpatient basis without referral. Technical support to the health system is required to jump-start the process; however once started, a sustainable adoption of this intervention by the health system can lead to decrease in mortality and morbidity in young infants.

Supporting information {#sec046}
======================

###### 

(DOCX)

###### 

Click here for additional data file.

###### 

(DOCX)

###### 

Click here for additional data file.

###### 

(DOCX)

###### 

Click here for additional data file.

###### 

(DOCX)

###### 

Click here for additional data file.

###### 

(PDF)

###### 

Click here for additional data file.

###### 

(PDF)

###### 

Click here for additional data file.

Dr. Makarand Ghorpade, study coordinator, KEM Hospital Research Centre Pune for helping to coordinate study activitiesTechnical Support Unit members including Dr. Arti Kinikar, Dr. Sanjeevkumar Jadhav and Dr. Ashish Bharti for providing technical overviewTaluka Health Officers of Junnar, Ambegaon and Khed blocks, Health Department, Zilla Parishad, Pune for supervising PHC staffMOs, ANMs and ASHAs of all eight study PHCs, Health Department, Zilla Parishad, Pune for implementing PSBI guidelinesDr. Harish Chellani; Dr. Sugandha Arya, Indian national IMNCI master trainers for conducting the study trainingField Research Assistants and clinical coordinators of KEMHRC team for supporting the PHC staffKaushik Ghosh, developer of data management system in Redcap

10.1371/journal.pone.0236355.r001

Decision Letter 0

Thet Wai

Khin

Academic Editor

© 2020 Khin Thet Wai

2020

Khin Thet Wai

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

22 May 2020

PONE-D-20-03227 Simplified management of young infants with possible serious bacterial infection (PSBI) when referral is not feasible in tribal areas of Pune district, Maharashtra, India: Implementation research for demonstration of feasibility and scale upDear Dr. Roy,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by May 30 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Khin Thet Wai, MBBS, MPH, MA (Population & Family Planning Resear

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

This is the important study contributing towards the reduction in neonatal mortality in a resource-limited scenario. Authors have identified the service delivery outcome of the simplified management of PSBI among young infants as well as the implementation outcomes that is fidelity and feasibility.

In general, English language correction is deemed necessary.

In addition, authors should fulfil the following requirements to further strengthen the scientific rigour in reporting the implementation research.

1\. To include key reference published in WHO Bulletin

Hales S, Lesher-Trevino A, Ford N et. al.

Reporting guidelines for implementation and operational research.

Bulletin of the World Health Organization 2016;94:58-64. doi: <http://dx.doi.org/10.2471/BLT.15.167585>

2\. The authors needed to clarify the existing knowledge gaps for implementation barriers towards the service delivery guidelines in the Introduction section. What was the nature and severity of the problem?

3\. P. 6 LINES 119-120: This is a multisite and multi-country study. Please mention other countries supported by WHO to participate in this study to avoid competing interest in publication ethics.

4\. To submit tools used for the baseline survey as additional files.

5\. To add one Table to illustrate the results of the baseline survey clearly.

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1.    Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please address the following:

\- Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section.

\- Please include additional information regarding the survey used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a survey as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

3\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4\. Please upload a copy of Supporting Information Table 1-2 which you refer to in your text on page 7 and 14.

5\. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: <http://journals.plos.org/plosone/s/licenses-and-copyright>.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf>) and the following text:

"I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form."

Please upload the completed Content Permission Form or other proof of granted permissions as an \"Other\" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: "Reprinted from \[ref\] under a CC BY license, with permission from \[name of publisher\], original copyright \[original copyright year\]."

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder's requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): <http://viewer.nationalmap.gov/viewer/>

The Gateway to Astronaut Photography of Earth (public domain): <http://eol.jsc.nasa.gov/sseop/clickmap/>

Maps at the CIA (public domain): <https://www.cia.gov/library/publications/the-world-factbook/index.html> and <https://www.cia.gov/library/publications/cia-maps-publications/index.html>

NASA Earth Observatory (public domain): <http://earthobservatory.nasa.gov/>

Landsat: <http://landsat.visibleearth.nasa.gov/>

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): <http://eros.usgs.gov/#>

Natural Earth (public domain): <http://www.naturalearthdata.com/>

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Partly

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors should be congratulated on the execution of an important implementation study for LMICs. Of note, this implementation programme is noteworthy for its attention to sustainability, and the write-up for its detailed description of the programme that fosters reproducibility.

This study has many important strengths that make this manuscript a valuable addition to the literature on the topic. The authors describe the successful implementation of identification and management of PSBI in young infants in concert with the public health system. The clear roles of the research team versus the public health system support the sustainability of this effort.

Despite these strengths, the manuscript requires major revision with respect to its conclusions. The programme demonstrates successful outpatient management of young infants with FB from 7-59 days. This population typically does not warrant referral per WHO criteria. However, the authors overstate what can be drawn from this programme regarding outpatient management of PSBI when referral is not feasible. Only 9 cases in this cohort fell into this category;

As such, attention should be paid to revising the following:

1\) Full Title should be revised; the short title is more appropriate, as the bulk of the evaluation is around feasibility of identification and management of PSBI when referral is possible, or when referral is not indicated

2\) Abstract should be revised based on the revisions made to the rest of the manuscript

3\) The extremely low rate of pre-referral doses of gentamicin is concerning. This does not bode well for MOs/ANMs being confident in administering gentamicin for young infants when referral is not feasible. Among the 9 infants treated as outpatient, only 2/3 received all gent injections. More attention should be given to this problem of lack of confidence in the discussion.

4\) the facilitators and challenges faced in the results section could be strengthened by a systematic look at facilitators and barriers using a validated implementation science framework such as the Consolidated Framework for Implementation Research. This would reduce bias in the results presented.

5\) The discussion needs to be re-written.

a\. paragraph 2 of the discussion: this conclusions should be placed in the context of prior literature on the topic. Do prior studies with larger sample size already demonstrate FB in 7-59 day young infants could be effectively treated on an outpatient basis? If their sample sizes were smaller, cite them. If they were larger, reframe the importance as demonstrating it is FEASIBLE to enact this recommendation with the kind of programme you implemented.

b\. line 472\-\--these numbers are too small to make conclusions about helping to reduce neonatal and infant mortality. soften this statement.

c\. paragraph starting with line 475\--coverage with this programme is a HUGE strength. more attention should be paid to this aspect. what was key in this programme with respect to improving how providers identify infection?

d\. paragraph starting with line 479\--also important to emphasize that the high acceptance of referral could limit generalizability of this study to settings where such high referral is not possible

e\. line 512: is it fair to say heistancy was \'minimized?\' the data would suggest that they remained hesitant given the very low numbers or pre-referral gent administered

f\. paragraph on line 529\--this reference is randomly inserted. please add text linking why this is relevant to the current study

6\) Conclusion is overstated. you demonstrated id and simplified management of PSBI and pneumonia in young infants can be feasibly implemented in a population where referral is nearly always possible. re-word.
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3\) In general, all figures on the PDF I reviewed were blurry. Legibility should be improved.

4\) Figure 3: This seems more like a flow chart to guide clinical identificaiton and management of young infants with PSBI rather than a flow chart of \'study activities.\' Suggest re-labeling.
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11\) Figure 4: label the y-axis
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Author response to Decision Letter 0

15 Jun 2020

We, the authors, thank the reviewers and the journal editorial team for their valuable comments and suggestions, which have helped to improve the quality of the manuscript. We have responded to all the comments and have incorporated the suggestions. Our responses to the comments are marked in blue in the attached document on responses to reviewers. We have also replied to the comments in the revised manuscript with track changes.

Reviewer\#3 (Abadi Leul)

Introduction

• Lines 68 -- 69: Reference number five says 92 % of all neonatal infections (not illnesses) are caused by bacterial infection. Neonatal infection is responsible for 46% of neonatal illnesses. Check and correct please.

We have corrected this as: bacterial infections accounted for 92% of the known causes of death due to possible serious bacterial infections. For better clarity, we have now also included mean incidence of bacterial infection (13.2% per 1000 livebirths).

• Line 83: Here please either mention all the regimens used in the AFRINEST and SATT studies or remove either procaine penicillin or Amoxicillin. Mention also Pneumonia in 7 -- 59 days can be managed effectively without the need for referral as you have implemented this approach as well.

We have modified the text appropriately by removing the mention of penicillin and amoxicillin. The revised text is as follows:

"Subsequently, a series of several large community based, multi-centre randomized trials in African and Asian populations (known as AFRINEST \[African neonatal sepsis trial\] and SATT\[Simplified Antibiotic Therapy for Sepsis in Young Infants\]) demonstrated the effectiveness of simplified antibiotic regimens containing injectable gentamicin, procaine penicillin and amoxicillin in out-patient settings among neonates and young infants up to two months of age with signs of PSBI where referral was not feasible."

• Lines 86 -- 87: Please check your reference. Reference number 17 and 18 is about home based new born care but could not get the section which describes about PSBI.

• Thank you for pointing this out. We have replaced the references with the following references.

Reference no. 18. Government of India. Operational Guidelines for use of Gentamicin by ANMs for management of sepsis in young infants under specific situations. Ministry of Health and Family Welfare, Government of India, Feb 2014. Available at <http://tripuranrhm.gov.in/Guidlines/2606201401.pdf> accessed 26th May 2020.

Reference no. 19. Government of India. Addendum to Operational Guidelines on Use of Gentamicin by ANMs for Management of Sepsis in Young Infants under Specific Situations. Available at <https://nhm.gov.in/New_Updates_2018/Om_and_orders/rmncha/child_health/Addendum.pdf> accessed 26th May 2020.

Methods

• Lines 113 -- 114: The outcome is not clear. What do you mean when you state "All or at least 80% of identified sick young infants will receive treatment." This outcome is not clear. It means for me whatever the rate of identification you will provide at least 80% treatment. One of the challenges in management of neonatal infections is most of them are not being identified. It is not problem of provision of treatment if identified. Of course referral acceptance is an obstacle to get treatment. I would suggest to re write the two out comes as objective

1\. To identify at least \_\_ % of all expected PSBI cases

2\. To provide adequate treatment to at least \_\_\_% of those identified.

The same lines better to avoid all or at least are enough

We agree that an estimate of the coverage of identification is an important indicator. We reported these objectives as such because they were listed as the objectives in our study protocol. However, we have now modified the text as follows:

"At least 80% of identified sick young infants will receive treatment.

At least 80% of the identified sick young infants will receive adequate treatment (Adequate treatment was considered as antibiotic doses for the first two days followed by at least 70% of doses over the next five days.)

We have calculated coverage and discussed about it in the sections on results and discussion.

• Line115: I see no difference in defining adequate treatment as taking full doses of amoxicillin (10 doses) and five days of injectable gentamicin. In case there is a difference elaborate.

We have explained this in the section on implementation of simplified management of sick young infants below and in the objectives kept it as 'all doses of recommended treatment'.

Design

• Lines 124 -- 125: Which WHO guideline is this. Put a reference.

• There are also two options that I know in the WHO guideline. It seems that you choose to use the seven days regimen that comprises 7 days gentamicin injections and twice oral amoxicillin per day for 7 days. Provide justification to use this regimen.

Please see below the response to both these comments:

The WHO reference we used was:

Reference no. 22. Integrated Management of Childhood Illness: management of the sick young infant aged up to 2 months. IMCI chart booklet. Geneva: World Health Organization; 2019. License: CC BY-NC-SA 3.0 IGO.

This regimen was chosen after discussions with the Government of India, which recommends the seven-day antibiotic regimen for PSBI.

References:

Reference no. 18. Operational Guidelines for use of Gentamicin by ANMs for management of sepsis in young infants under specific situations. Ministry of Health and Family Welfare, Government of India, Feb 2014. Available at <http://tripuranrhm.gov.in/Guidlines/2606201401.pdf> accessed 26th May 2020. Reference no. 19. Addendum to Operational Guidelines on Use of Gentamicin by ANMs for Management of Sepsis in Young Infants under Specific Situations. Available at <https://nhm.gov.in/New_Updates_2018/Om_and_orders/rmncha/child_health/Addendum.pdf> accessed 26th May 2020

We have also added the following in the section on 'Trainings and Orientation': The algorithm for identification and management of PSBI was prepared from adopting updates from the WHO PSBI guidelines guideline on managing PSBI in young infants when referral is not feasible to the WHO young infant IMCI chart booklet, 2019. Although the WHO young infant IMCI chart booklet was printed in 2019, the draft was used to adapt the Indian guideline to manage PSBI when referral was not feasible.

Policy dialogue for implementing adapted guidelines

• Line148: Could not see supplemental table 1.Is it in a different attachment than the figures.

We seem to have missed to include this supplementary table initially, have added this along with the re-submission.

• Line 158 -- 159: What is the difference between RST and TSU? Don't they have the same task? It is not clear why you divided them into two. I feel the RST is in the TSU. If that is the case IT and TSU may be enough to make things clear.

The TSU was an oversight body with senior independent experts and study investigators. It was not involved in the conduct of the study, it only met four times during the study to provide guidance and suggestions. The RST was involved in day-to-day study activities, including supporting the implementation team (IT), regular supervision and analysis. Thus, the TSU was completely independent of the RST. We have now clarified this in the text.

Study area

• Better to re write to keep the flow. Also give a summarized picture of the study area. Total population covered. Expected live births in the catchment area in 20 months

.Available health facilities from the lowest level to the highest level in the district. How are they staffed under normal circumstances based on the government policy e.g., What are the staffs available at the sub centers PHC, rural hospitals and district hospital? What can they do? Distance between each level of care and catchment population for each tier level.

Thank you for this suggestion. We have added details of the study area in a panel in figure 3 as well as a table (supplementary table 2) that gives a summary of the study area.

• Line 177: check the number.

Yes, we have confirmed this number. As this is a tribal area, it is relatively less densely populated

Baseline survey and mapping of referral system

• General the following should have been included in the base line assessment

The existing services in the PHC and sub center? Activities in relation to PSBI cases? Whether they are identifying these cases and what do they do.

You should have also assessed the MOs the same way as ANM/ASHA

We have included these details in a panel in figure number 3

• Line 185: what are ANMs? Don't start with abbreviation in the first time.

We have explained above in a panel in figure number 3

• Line 86 -- 87: what are ASHAs? You didn't describe them before?

We have explained above in a panel in figure number 3

• Line 194: IT team activities. I don't see the importance of this title. You can continue with the training and orientation you are describing about training of the master trainers from the TSU.

We have removed the title "IT team activities".

• Line 200: Reference 21 is the 2019 WHO guideline. The training was given in 2017. Please recheck this.

We have explained this as: The algorithm for identification and management of PSBI was prepared from adopting updates from the WHO PSBI guideline on managing possible serious bacterial infection in young infants when referral is not feasible (17, 22) to the WHO young infant IMCI chart booklet, 2019 (23). Although the WHO young infant IMCI chart booklet was printed in 2019, the draft was used to adapt the Indian guideline to manage PSBI when referral was not feasible.

• Line 206: Fig. 3 Needs rearrangement. Based on the WHO guideline PSBI includes FB in young infants 7 -- 59 days as well. Please check and correct.

We have changed the figure accordingly \[now figure 4\].

Identification of sick young infants

• Line 217: What is this higher level? You have Rural and district Hospitals. Are these the referral sites or you have a tertiary level. If different one please provides its distance and the neonatal services in this level somewhere.

We have included this in a panel in figure number 3: Civil hospital, Pune: This is a district-level tertiary care hospital with neonatal intensive care facilities and is located in Pune district at an average distance of 80-140 kilometres from the study area. This was the primary referral centre in the study.

Referral to tertiary health care facilities

• Line 225: It is not clear why you were bypassing the rural and district hospitals. Please explain why this happened. What is the purpose of these hospitals if they don't serve as referral sites for PSBI cases?

We have added in the text: The rural hospitals and sub-district hospitals only manage uncomplicated infection cases in infants, and provide immediate post-natal care but and do not have neonatal intensive care facilities to and do not admit or manage serious illness. PSBI cases. Hence these were not considered as referral facilities for PSBI cases. They have been described here to give a complete picture of the health infrastructure.

• Line 226: Was this the pre referral regimen for India. Is it different from the WHO recommendation which was giving gentamicin and oral amoxicillin?

As per the Indian study guidelines, only intramuscular Gentamicin was given as pre-referral antibiotic dose.

Treatment when referral is not feasible or referral is not recommended

• Lines 234 -- 236: Are you sure you gave oral amoxicillin and gentamicin injection for CI. Is this in your guideline? Please separate CSI from CI. I feel it is by mistake. You may give ampicillin injection instead of amoxicillin?

This was an error made initially; we have now mentioned the appropriate treatment for CI. Infants with CI were started on a course of intramuscular ampicillin and intramuscular gentamicin daily for seven days.

• Line 237: Why is the MOs work only consultation? These are the most vulnerable babies and they should get the maximum care by the most senior person in the PHC.

We agree and in our study the MOs had overall responsibility for identification of PSBI, choosing the appropriate treatment and administering the treatment. However, in many cases, once the first dose of antibiotics was administered, the infants would follow up with ANMs, who were fully trained to continue to administer the antibiotics.

We have now modified the text to "All doses of injection gentamicin and first daily dose of oral amoxicillin were administered by the MO or ANM in consultation with the MO at the PHC".

Monitoring and follow up

• Line 246 -- 248: Who was doing the follow up and where? Why only on day 4 for FB pneumonia. Was there any follow up after they finish their treatment to know the outcome?

Thanks for pointing out this error. We have now corrected as: all FB cases were followed up on the 4th and 8th days of starting treatment.

Activities of the KEMHRC RST

• Line 263 -- 264: Please state how the consultation was made? And whether it was random consultation or regular for every case? If regular how often?

Consultations were made for approximately 10% of all PSBI cases, not for all cases. The consultations were always initiated by the MOs/ANMs. There was no pre-decided pattern for consultations. We have updated this in the text.

Communication

• Line 278 -- 280: Please mention here how frequent was this done? How many cases were assessed using this application? How accurate were they in classifying and identifying treatment? Better if you have data as this is one of the best ways of remote consultations?

Whatsapp technology was used for consultation in 5-6 cases of PSBI. However, this was done after PSBI classification was done by MOs/ANMs and only for confirmation. We did not asses the validity of this technique in the study, hence we cannot comment on its scientific accuracy. We believe that this is a technology for remote consultations in our set-up. We agree that this may need separate validation studies, but it was out of scope of this project.

• Line 279 -- 280: How frequent was this meeting held. How did it help in bringing changes?

We have added this in the text: These meetings were held once every month for the initial five-six months as most of the challenges were identified during these initial months into the study and thereafter, once every three months. These helped in devising solutions to improve case identification, ensuring uninterrupted supplies of medicines and consumables and ensuring referral mechanisms could function appropriately.

Results

This section has important findings but needs major revision. Coverage calculation seems to be from the actual cases identified. As well all know one of the major challenges in the management of PSBI in resource limited countries like India is identification of these newborns. Hence calculation of coverage is very important. The coverage depicted here shows only coverage for identified. The key finding and informative for policy change will be identification from the expected live births. Hence you need to indicate in your study area (please look comment in the section study area description). Look also comments in each section.

• Line 294 -- 296: Need to rephrase it as

The public health system has successful managed 90% of the PSBI cases identified during the study period independently while 10% required consultation with the RST implying the study was implemented as planned.

We agree with this statement but found it relevant for inclusion in the discussion section and have added this statement in the first paragraph in discussion section.

Baseline Survey:

• Based on your findings please show the referral system (How these different health facilities are linked each other. Which once are the referral sites for PSBI cases? Why the secondary level of health care was were bypassed. How are the private institutions staffed? Also describe their exact number. How few are few?

We have depicted the referral system in figure 3. The rural hospitals and sub-district hospitals do not have neonatal intensive care facilities and do not admit or manage PSBI cases. We have now mentioned in the methods section. Hence these were not considered as referral facilities for PSBI cases. These hospitals manage only uncomplicated infection cases in infants and immediate post-natal care.

There were approximately 8-10 private health facilities, within the study area, with 2-3 some having intensive care units. We have updated this in the text. We did not perform a health facility survey for private health facilities as part of this study, hence we do not have the exact numbers. These private health facilities varied in terms of their capabilities, with in-patient capacity ranging from 5-20 beds and staff consisting of a mix of doctors, nurses and support staff.

• Supplemental table 2. I could not access it. Reload it or indicate where it is. At least not with the attached supplements.

We seem to have missed to include this supplementary table initially, have added this along with the re-submission

• Line 312 -- 321: This paragraph needs to be re written clearly. Some of the data are not uniform example you said "....about 80%-85% ASHAs were aware about danger signs in young infants and counselling for newborn care. Then ..... Only 55-60% ASHAs was aware of danger signs in young infants"

Thanks for pointing out the error. We have corrected it as: 80%-85% ASHAs were aware about overall care of young infants and counselling for newborn care However, Only 55-60% ASHAs were aware of danger signs in young infants.

• The ANMs have never identified PSBI cases before. Does this mean no NB was coming at all or how what were they doing when a new born comes to them? Clarify in order to understand.

Have added this: Before initiation of this project, sick young infants approaching the PHCs were routinely referred to higher-level health facilities by MOs.

• Line 326: Mention the strength of Gentamicin available at that time?

Have added: vials in a dose of 80mg/2ml.

Birth surveillance and postnatal visits

• Do we know how much of the expected live births were identified? This is the main reason for compromising identification of PSBI cases as seen in other studies. According to the World Bank 2017 report the estimated live births in India was 18.08/1000population. Hence your area should expect 139942\*0.01808/year which is equivalent to 4217 LB. You have identified only 2001. I assume that many might have delivered in the rural and district hospitals as they are relatively accessible. You may be able to estimate the proportion of the mothers who had follow in these hospitals and proportion missed taking the local circumstances. Taking this into consideration you can estimate the coverage otherwise it does not give sense calculating from the identified. Infact it should have been 100% if you calculate from the identified. I feel this has also affected your coverage of PSBI. I recommend you to give justifications for this.

During the study period of August 2017 to March 2019, the study recorded totally 3071 live births in all institutions. Of these 3071 births, 2001 were in public health facilities and were followed up for post-natal home-based care by ASHAs. Based on this number of 3071 live births, we could follow 2001 (65%) births. We have updated this in the text.

• Table 1: Title Follow the guideline given by PLOS.

We have changed the title

• Either you can omit this table and describe or better if you add coverage from expected.

We have added a column and moved this table to the supplementary tables document.

Identification and referral of sick young infants

• This section requires major revision

Your result mainly focuses on treatment not on identification. If I am correct WHO needed this implementation research mainly how to identify young infants with PSBI and then provision of adequate treatment? Your result in terms of provision of treatment is very nice. As I can see from your main aim of the research as well is focusing only on treatment. I was expecting coverage as well. I don't think the number of PSBI cases expected was only 200 in 20 months in this district. If you correct the expected live births then you will get the answer. I am thinking many PSBI cases have gone directly to the private clinics and government hospitals. Is it possible to get this data or at least put estimation? Unless we have that data it will be difficult to accept 87.5% coverage of identification in this catchment.

The other issue is that in your description it seems that FB pneumonia in young infant 7 -- 59 days is not considered as PSBI. Hence this part needs to be re written.

Have reworded this: A total of 545 sick young infants were assessed during the study implementation phase, of which 175 90 had signs of PSBI (34 CI, 46 CSI, 10 FB in 0-6 days old infants and 85 infants aged 7-59 days with FB). Assuming a 10% incidence (5, 13, 14, 15, 16) of PSBI among all live births, with 3071 live births recorded, the expected number of young infants with any sign of PSBI or including FB in 7-59 days old would be 307.We identified and treated 175 young infants with PSBI, indicating actual coverage of 57%.

We did not collect data from private clinics and government hospitals as this was outside the study protocol. We agree that some infants would have been identified at these hospitals and the actual coverage may need a correction factor. However, we have not attempted to estimate this factor in this study. The purpose of this study was to demonstrate the feasibility of implementing the PSBI management intervention in the public health system. Coverage by this public health system, though an important indicator, may not be very high in places where private health facilities are available.

• Lines 351 -- 354. You have young infants sent to the sub centers. Can you separate those sent to the sub centers and to the PHC and then describe how they were managed and/or referred. The same is true as to who evaluated them MOs/ ANMs. Do we know how many were evaluated by MOs and ANMs separately? Do we know the reason why all were not seen by the MOs if these are the most senior people you have in the PHCs.

This is an important piece of information and we appreciate the questions on this. However, while we have data on pathways to treatment, we have deleted the pathways here since that in itself is a separate analysis. It includes at least five different pathways to treatment seen in the study and would greatly increase the content of this manuscript. For example, each pathway would have person and place of identification, followed by person and place of first assessment, and sometimes, second assessment, person and place of starting treatment and outcomes. This comment, though, does give us an idea to conduct this analysis and write a separate manuscript; we will follow-up on this and thank the reviewer for this suggestion.

We have reworded this section to only specify identification.

• Table 2. Follow guideline given by PLOS and correct the title of the table accordingly.

We have modified accordingly. (Now table 1)

• Line 366 -- 368: Mention whether all have received pre referral treatment? If yes what pre referral treatment was given?

Have added to the text: Pre-referral doses of gentamicin were given in only 7.1% (6 out of 84) PSBI before referral to higher centres.

• Line 378: Correct as 175 not 185.

Corrected to 175.

• Line 380: WHO doesn't recommend very low birth weight to be managed as PSBI at community level and it was one of the exclusion criteria in the AFRINEST and SATT trials. Does your implementation include VLBW?

VLBW infants were supposed to be referred and not managed at PHC as per protocol.

• Line 382: Which one is your tertiary referral level? Is it the district hospital? If that is considered the tertiary referral level please describe some where the referral site is the district hospital.

We have added sentences in the methods section of the manuscript explaining that the Civil hospital was the referral hospital. The rural hospitals and sub-district hospitals do not have neonatal intensive care facilities and do not admit or manage PSBI cases. Hence these were not considered as referral facilities for PSBI cases. These hospitals manage only uncomplicated infection cases in infants and immediate post-natal care. Have also mentioned in the newly added section on health infrastructure that the Civil Hospital is a district-level tertiary care hospital with neonatal intensive care facilities and is located in Pune district at an average distance of 80-140 kilometres from the study area.

• Line 383 -- 384: Just wondering how he received treatment at the PHC. Was he able to take the PO medication\> state the medication that he took. Give the reason why the mother refused treatment on the second day. How comfortable was the HCP to treat such babies.

One received two doses of oral amoxicillin and no injection gentamicin and the other one received three days treatment with injection gentamicin and oral amoxicillin. The MO/ANM were prepared to administer complete treatment for 7 days, however both the parents refused treatment without giving any specific reasons.

• Table 3. The same follow PLOS guideline

We have modified the table accordingly. (Now table 2)

• Better if you remove the column on FB pneumonia. It is misleading. It says 22 accepted referral which is 26%. These are not offered referral rather did not accept the treatment at PHC. 26% is big. Try to explain why they have declined to be treated at the PHC rather.

We have removed data for FB in 7-59 days and coloured the column grey. Have discussed this in the discussion section.

• One young infant with FB pneumonia came to the PHC and refused both treatment and referral. It is interesting to know why he came and why he refused every offer. It is unusual; finding and better to explain if we know the reason.

The reason was that the parents had planned to immediately migrate out of the study area and did not want to start treatment from the PHC.

Treatments given to sick young infants when referral was not recommended or feasible

• Please separate CSI and CI who refused referral and those with FB who were treated without offering referral to make it more informative.

We have presented results separately for CI, CSI, FB in 0-6 days when referral for not feasible and for FB in 7-59 days where referral is not recommended.

• Line 401 -- 402: Please explain why pre referral treatment was given only to 6/81 young infants. Why was it not corrected during the process of implementation?

Have moved this to section on Referral to government or private tertiary care and management of sick young infant at PHC/SC in the manuscript. This has been discussed as a challenge faced in the study.

• Line 402 -- 404: This is contradictory to what you have reported in those who did not accept referral. You stated that they have treated VLBW infants. If the ANMs/MOs were not trained to give Im gentamicine, who gave treatment to the one baby who refused referral for one day. Check this with line 382 -- 384. This needs explanation or correction.

MOs/ANMs were trained to give Gentamicin and as seen in table 4, have given gentamicin to 7 PSBI infants who refused referral. However, this was a specific incidence at one PHC and have clarified that MOs/ANMs of that particular PHC refused to treat such very low birth weight babies

• Line 403: Put the exact weight than saying \<1.5 kg

Have done accordingly.

• Line 405: Does that mean he was cured without any intervention. You can leave this as there is nothing to learn from this.

Have added: This infant had hypothermia and movements were lesser than normal. Breastfeeding was initiated and continued adequately.

• Table 4. Follow PLOS guideline.

Done accordingly (Now table 3)

• Fb only Pneumonia in 7 -- 59 days: Is it 63 or 62? Check and correct.

It is 62, have corrected this.

Study Progress and facilitators and challenges for implementation

• General comment on this issue is related to the results. Unless we get the number of young infants going directly to the rural Hospitals and district Hospitals which I feel is the case. It is very difficult to generalize that your case identification has improved. Still this section needs revision if the result you put is the same. It is expected that there are at least equal number of babies that you failed to identify considering the PSBI cases that you expect in the district. But it may be true that most of them have gone directly to the nearby hospitals or went out of the catchment. I recommend to explain this.

We appreciate this suggestion. We did not collect data from these hospitals as this was outside the study protocol. We agree that some infants would have been identified at these hospitals and the actual coverage may need a correction factor. We have added this in the discussion section.

• Fig 4. Needs rearrangement. PSBI includes all. Hence better to change the legend as Total PSBI, CSI/CI and the FB pneumonia in 7 -- 59 days. Then the increment is on FB pneumonia while the CSI/CI is declining. How do we explain this?

We have done accordingly.

• Line 441 -- 444: In your IR it seems that the rural and district hospitals were by passed to a tertiary level. If no PSBI case was being seen before the IR then where were these babies seen? If they were seen in the rural and district Hospitals, this is going to be a shift from a relatively equipped health facility to a lower and less equipped facility. The activities of these hospitals were not explained. Do you have this data?

We have added details of these hospitals and why these were not referral centres in the methods section

• Line 445 -- 446: What does 53.3% indicate? The eligible ones to be referred were 90 PSBI cases and of which 90% accepted referral (line 365). Check this and keep consistency in descriptions.

We have modified as follows: A robust and effective referral system ensured that a majority \[81 out of 90 (90%)\] of young infants with PSBI, who were eligible for referral to government tertiary care health centres, actually accepted referral to such centres

Challenges faced

• Table 5: As in other tables.

Done accordingly. (Now table 4)

• Row number 3: Why was it a challenge if they want to go to private centers as far as they provide appropriate treatment? Do we know their capacity to consider this as a challenge? You did not show their limitations in your description of study areas. In fact they should have been included in this IR as many babies might have gone there.

While we did not evaluate private health facilities in the study, we cannot say anything about quality of care at private facilities or appropriateness of their treatment. Further, from studies on antibiotic prescriptions, it has been seen that very few private facilities treat infections in children with simplified antibiotics such as gentamicin and amoxicillin, with most preferring cephalosporins (28, 29). In addition, we are not sure if these were affordable for the study population. This aspect needs further investigation and we agree that the private health sector, where available, can play a valuable role in managing sick young infants. We have discussed this aspect in the discussion section.

• Row 4: Do you think you have solved this challenge? Only 6 babies received prereferral treatment out of 81 not 11 by the way. (Correct this). How come you are satisfied to say you have solved this challenge? It seems it has persisted throughout the implementation processes. Give explanation

Have corrected the number. We have clarified that this was not satisfactorily resolved in the study in the discussion section.

• Row 6: During which phase was this?

This was seen in the first three months of the study.

• Row 7: It is confusing. The nurses where giving gentamicin for VLBW who did not accept referral but not for pre referral. Rationale? Most countries including WHO guideline doesn't include VLBW in these classifications. You did not mention about the difficulty of giving amoxicillin for these babies whom I feel is more difficult.

Have clarified this: MO/ANMs were trained in administering injections even to VLBW babies as part of routine immunizations; they were not confident of administering gentamicin for fear of adverse events. The MO/ANMs did not report any difficulty in administering amoxicillin to VLBW babies.

Discussion

• General comment

The discussion part is well discussed but the problem lies on calculating coverage. Unless otherwise explained the coverage of identification of PSBI in this district is not satisfactory. May be the private centers and the three hospitals are taking major share. Here either include data captured from these sites or assume based on reasonable reasoning that certain amount has gone to these sites. Please re calculate the coverage for identification of PSBI. See comments in result section.

Have responded to these comments partly in the results section..

Have also added the following in the discussion section: We had reasonable treatment coverage of a little less than 60% in our study. Similar implementation research studies on PSBI in young infants from African and Asian countries reported treatment coverages of 16.3% in Sylhet and Chittagong in Bangladesh (23), 50% in Ethiopia (24), 42% in Kushtia district, Bangladesh (25), 63.8% in Malawi (26) and 95% in Nigeria (27). Thus, except for the Nigeria study, our coverage proportions are comparable with other reported coverages. However, our coverage could have been higher; a major factor in our study area was the preference of private health facilities which might explain where the remaining estimated 40% cases of PSBI would have been managed. Another factor could be that some PSBI cases visited the sub-district and district hospitals directly. However, we did not collect data from these hospitals as this was outside the study protocol. We agree that some infants would have been identified at these hospitals and the actual coverage may need a correction factor.

• Line 492 -- 495: This part is good\> If you had this information that even those who came to the PHC were preferring the private facilities the you should have collected data from those who went direct to the health facility. This is important as the main objective off WHO is identifying all young infants with PSBI and make sure that they receive adequate treatment including simplified antibiotics no just getting treatment at the PHC.

MO/ANMs were able to ascertain preference for private facilities only after these cases came to SC/PHC and were diagnosed with PSBI. There was no scope for separate data collection from those who directly went to private facilities. Primary reasons given for private preference were relatively more confidence in and relative ease of negotiating private health-care processes. In fact, this finding from the study will help to inform policy regarding PSBI management when referral is not feasible to a larger public sector hospital, wherein greater public-private partnership in health can be a recommendation to reduce infant mortality. However, from studies on antibiotic prescriptions, it has been seen that very few private facilities treat infections in children with simplified antibiotics such as gentamicin and amoxicillin, with most preferring cephalosporins (28,29). In addition, affordability of such facilities remains a challenge, especially for the tribal communities as in the study area. Thus, a balanced view about the appropriateness, affordability as well as accessibility of private health facilities needs to be considered.

• Line 503 -- 504: Do we know the reasons why we did not achieve our expected output which was to provide at least 80% quality treatment? Discuss some explanations

Have reworded and added in the text: The quality of treatment received at PHC level was appropriate for around 65% of the CSI, CI and FB in 0-7 days PSBI cases in those who accepted the treatment. While this was based on only 9 cases for which referral was not possible, we admit that even for such a small number, the quality should have been higher.

• Line 507 - 509 -- was this problem continued till the end or remained a problem. Explain this. If this remains to be a problem then how do you see the ownership of this programme?

This problem did not continue as the confidence of primary healthcare workers mainly ASHAs and ANMS increased with time for identification and treatment of the sick infants. Relevant statement is added to the discussion.

• Line 538 -- 541: Another way of looking effectiveness of such programmers is the change in the identification and treatment coverage of young infants with PSBI in the whole district compared to the previous years other than looking in to the increment at the PHC level only. How do you see your involvement in the community training on newborn danger signs by the ASHAs? Did it bring improvement in care seeking and more and more kids are going to the other centers as well or are you bringing those who used to go to the other centers in to the PHC. If the later is the case this is not what is expected. In case you have data try to look into this as well.

We agree that this information would add value to the interpretation of our study results. We did attempt to obtain this data from other facilities in Pune district during the study, however we could not obtain any relevant data. Similarly, we did not measure care-seeking practices during this study; however, we, KEM Hospital Research Centre, are currently conducting a separate care-seeking study in under-five children in the same tribal areas and will get an estimate of whether the PSBI study led to any change in care-seeking preferences and practices.

Reviewer \#1:

The authors should be congratulated on the execution of an important implementation study for LMICs. Of note, this implementation programme is noteworthy for its attention to sustainability, and the write-up for its detailed description of the programme that fosters reproducibility.

This study has many important strengths that make this manuscript a valuable addition to the literature on the topic. The authors describe the successful implementation of identification and management of PSBI in young infants in concert with the public health system. The clear roles of the research team versus the public health system support the sustainability of this effort.

Thank you for your appreciation.

Despite these strengths, the manuscript requires major revision with respect to its conclusions. The programme demonstrates successful outpatient management of young infants with FB from 7-59 days. This population typically does not warrant referral per WHO criteria. However, the authors overstate what can be drawn from this programme regarding outpatient management of PSBI when referral is not feasible. Only 9 cases in this cohort fell into this category;

We have modified our conclusion accordingly. Also, in the discussion, we have included few numbers pf PSBI cases being managed at PHCs as one of the limitations.

As such, attention should be paid to revising the following:

1\) Full Title should be revised; the short title is more appropriate, as the bulk of the evaluation is around feasibility of identification and management of PSBI when referral is possible, or when referral is not indicated

Have changed full title to: Feasibility of implementation of simplified management of young infants with possible serious bacterial infection (PSBI) when referral is not feasible in tribal areas of Pune district, Maharashtra, India

2\) Abstract should be revised based on the revisions made to the rest of the manuscript

Have revised the abstract accordingly.

3\) The extremely low rate of pre-referral doses of gentamicin is concerning. This does not bode well for MOs/ANMs being confident in administering gentamicin for young infants when referral is not feasible. Among the 9 infants treated as outpatient, only 2/3 received all gent injections. More attention should be given to this problem of lack of confidence in the discussion.

Have highlighted this as a limitation and discussed the following in the discussion section: The hesitancy of ANMs to administer injectable gentamicin in young infants due to fear of adverse effects could not be was minimized sufficiently in spite of with refresher training and constant on-field support. This needs further examination and appropriate steps to improve this intervention of administering gentamicin. This was a limitation of this study indicating that there is a need for motivation and confidence-building, including support of senior public health authorities, of MOs, ANMs and ASHAs to administer pre-referral gentamicin.

4\) The facilitators and challenges faced in the results section could be strengthened by a systematic look at facilitators and barriers using a validated implementation science framework such as the Consolidated Framework for Implementation Research. This would reduce bias in the results presented.

Thank you, this is a useful suggestion. We also find the CFIR to be an appropriate framework for implementation research and would like to inform that the KEMHRC team is currently conducting an implementation research study using the CFIR to improve outcomes of high-risk pregnancies. However, we believe that using CFIR to determine facilitators and barriers would generate a lot of information that should be presented separately and it needs its own manuscript. We have focused on the overall feasibility and described the primary study findings in the current manuscript which is the first manuscript from the study; we will use your suggestion to present facilitators and barriers in more details in a subsequent manuscript.

5\) The discussion needs to be re-written.

a\. paragraph 2 of the discussion: this conclusions should be placed in the context of prior literature on the topic. Do prior studies with larger sample size already demonstrate FB in 7-59 day young infants could be effectively treated on an outpatient basis? If their sample sizes were smaller, cite them. If they were larger, reframe the importance as demonstrating it is FEASIBLE to enact this recommendation with the kind of programme you implemented.

Have added: In the Malawi study (already referred to previously in the text), out of 150 young infants with FB, cure rate was achieved in 96% infants (26). The study in Kushtia, Bangladesh reported that among 475 young infants with FB, approximately 80% of caregivers reported that their infant had received oral amoxicillin for five days and 74% for seven days and the treatment failure rate was approximately 5% (25). Similar proportions were reported in the Nigeria study with All 7--59 days old young infants with fast breathing who received treatment at the outpatient improved with oral amoxicillin (27). Thus, our study results had comparative results for outcomes of FB in 7-59 days infants, though, our numbers were lesser. Thus, it is feasible to enact this recommendation within the public health system in India.

b\. line 472\-\--these numbers are too small to make conclusions about helping to reduce neonatal and infant mortality. soften this statement.

Have added: However, considering the relatively low number of PSBI cases, we need to interpret this fatality rate with caution when applying to other areas as well as while scaling-up the intervention.

c\. paragraph starting with line 475\--coverage with this programme is a HUGE strength. more attention should be paid to this aspect. what was key in this programme with respect to improving how providers identify infection?

Have added: Ownership of the program and supervision by senior public health officials were crucial for achieving these coverage proportions. Along with it, support from the KEMHRC RST, especially in the early phase of the study played an important role in this. Have also added comparisons with other similar studies.

d\. paragraph starting with line 479\--also important to emphasize that the high acceptance of referral could limit generalizability of this study to settings where such high referral is not possible

Have added: The high acceptance of referral could limit generalizability of this study to settings where such high referral is not possible. Have also added comparisons.

e\. line 512: is it fair to say heistancy was \'minimized?\' the data would suggest that they remained hesitant given the very low numbers or pre-referral gent administered

Have changed this to: However, the hesitancy of ANMs to administer injectable gentamicin in young infants due to fear of adverse effects could not be was minimized sufficiently in spite of with refresher training and constant on-field support. This needs further examination and appropriate steps to improve this intervention of administering gentamicin.

f\. paragraph on line 529\--this reference is randomly inserted. please add text linking why this is relevant to the current study

Have moved this reference to the discussion on coverage at the top of the discussion section.

6\) Conclusion is overstated. you demonstrated id and simplified management of PSBI and pneumonia in young infants can be feasibly implemented in a population where referral is nearly always possible. re-word.

Have revised as: The study demonstrated that the identification and management of PSBI and their simplified management of PSBI and pneumonia in young infants can be implemented in a safe and effective manner at out-patient facilities in the public health system. when referral is not feasible. Fast breathing in 7-59 days old can be effectively managed with oral antibiotic on an outpatient basis without referral.

Additional revisions recommended:

1\) Figure 1: both the RST and IT \'provided training\' under activities; clarify in the figure how this was different ie what trianing and to whom?; the description about the TSU is vague\--ie what recommendations were being provided?

Have done accordingly.

2\) Line 176: Is there a zero missing from this number? \"1,40,000\"

This figure is correct. As this is a tribal area, it is relatively less densely populated.

3\) In general, all figures on the PDF I reviewed were blurry. Legibility should be improved.

Have revised the formatting of the figures.

4\) Figure 3: This seems more like a flow chart to guide clinical identificaiton and management of young infants with PSBI rather than a flow chart of \'study activities.\' Suggest re-labeling.

Have labeled it now as 'flowchart of PSBI identification and management'.

5\) Lines 311 and 313 seem contradictory. what percentage of ASHAs were aware of danger signs in young infants?

We made an error and have corrected it as: 80%-85% ASHAs were aware about overall care of young infants and counselling for newborn care However, Only 55-60% ASHAs were aware of danger signs in young infants.

6\) line 330\--did the public health system or RST provide weighing scales, thermometers etc.?

Have added in the sentence: by the RST

7\) line 343: do you mean 545 young infants were identified as potentially sick during the implementation phase? please clarify

Have reworded this as: A total of 545 sick young infants with some signs of illness were assessed during the study implementation phase, of which 175 had signs of PSBI (34 CI, 46 CSI, 10 FB in 0-6 days old infants and 85 infants aged 7-59 days with FB.)

8\) Table 4: the oral amox doses section of the table is confusing. Does received all 14 days of treatment refer to 7 days of gent and 7 days of amox? many of these rows do not apply to the FB 7-59day set of patients who only get 7 days of amox. Also please clarify what is meant by the comment associated with the \* in this table.

14 doses of amoxicillin indicate 7 days of amoxicillin with twice daily dosing. 7 days of gentamicin indicate 7 days of gentamicin with once daily dosing. Have coloured the cells for gentamicin in the column on FB in 7-59 days grey as this is not applicable. We have removed this \* sign and comment to avoid confusion; details are written in the text explaining the table.

8\) line 367: this sentence seems repetitive of the prior one in which it states on infant had CI among those treated on an outpatient basis

Have deleted this sentence.

9\) \#3 in the table on challenges\--it is unclear until you get to the discussion why is is problematic that many parents preferred private providers; add some explanation to clarify in the results section

Have added in the table: Primary reasons given for private preference were relatively more confidence in and relative ease of negotiating private health-care processes

10\) \#6 in the table on challenges\--the role of the RST here seems like one the public health system should have taken on? this may warrant comment in the discussion

The RST only coordinated with the public health system to ensure supplies, which was needed only in the first three months of the study period, the actual procurement was done by the primary health facilities. The RST deliberately did not intervene in the procurement mechanisms, the initial coordination was done to help in streamlining the processes.

11\) Figure 4: label the y-axis

Have labelled it as number of sick young infants.

Reviewer \#2:

Description of the study area has to be exhaustive. Number of staffs, their level of training and the referral linkages has to be clearly outlined. Coverage calculation has to be justified as per the comment given.

We have added a separate panel in figure no.3 that describes the health infrastructure. We have added coverage calculation in the first paragraph of the results section.

Supplemental tables are not attached or could not be downloaded. The whole manuscript needs to be checked according to the PLOS guideline. Font size, spacing,title and tables has to be revised.

We have submitted the supplementary tables and formatted the manuscript as per Plos One guidelines.

Additional Editor Comments (if provided):

This is the important study contributing towards the reduction in neonatal mortality in a resource-limited scenario. Authors have identified the service delivery outcome of the simplified management of PSBI among young infants as well as the implementation outcomes that is fidelity and feasibility.

In general, English language correction is deemed necessary.

In addition, authors should fulfil the following requirements to further strengthen the scientific rigour in reporting the implementation research.

1\. To include key reference published in WHO Bulletin

Hales S, Lesher-Trevino A, Ford N et. al.

Reporting guidelines for implementation and operational research.

Bulletin of the World Health Organization 2016;94:58-64. doi: <http://dx.doi.org/10.2471/BLT.15.167585>

We have edited the manuscript for language corrections. We have tried to follow the mentioned guidelines as far as possible and have added this reference in the methods section.

2\. The authors needed to clarify the existing knowledge gaps for implementation barriers towards the service delivery guidelines in the Introduction section. What was the nature and severity of the problem?

We have added following text in the introduction section:

However, implementation of such guideline in the public health system requires a multi-pronged approach and involves dialogue with the policy makers and program managers, understanding barriers and facilitators for implementation and providing technical support for implementation. While implementation challenges were well documented in controlled conditions in the above mention Asian and African countries, we could not find barriers to implementation of PSBI management within the public health system in India. Thus, an implementation research was planned across four different sites in India within the public health system to facilitate policy adoption and implementation of the WHO PSBI guideline. Maharashtra state has a relatively well functioning public health system and a private sector compared to many other states in India (20). However, its tribal areas still have poor access to health care due to lack of proper roads, inadequate number of health facilities as well as low level of income and education among tribal population (21). We describe here the process of implementation and outcomes of simplified management of PSBI in young infants in a tribal population from Western Maharashtra, India.

3\. P. 6 LINES 119-120: This is a multisite and multi-country study. Please mention other countries supported by WHO to participate in this study to avoid competing interest in publication ethics.

Have added this: The other countries supported by WHO in this study were Democratic Republic of Congo, Ethiopia, Malawi, Nigeria and Pakistan.

4\. To submit tools used for the baseline survey as additional files.

We have submitted tools used in baseline study used this study.

5\. To add one Table to illustrate the results of the baseline survey clearly.

We have added a table showing the main findings as supplementary table number 4.

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

We have done accordingly.

2\. Please address the following:

\- Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section.

\- Please include additional information regarding the survey used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a survey as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

Instead of preparing a separate section on limitations, we have specifically written about limitations throughout the text of the discussion section.

3\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

We have taken note of this.

4\. Please upload a copy of Supporting Information Table 1-2 which you refer to in your text on page 7 and 14.

We have uploaded a document on supplementary tables.

5\. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: <http://journals.plos.org/plosone/s/licenses-and-copyright>.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1\. You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (<http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf>) and the following text:

"I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (<http://creativecommons.org/licenses/by/4.0/>). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form."

Please upload the completed Content Permission Form or other proof of granted permissions as an \"Other\" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: "Reprinted from \[ref\] under a CC BY license, with permission from \[name of publisher\], original copyright \[original copyright year\]."

2\. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder's requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

We have edited the figure to include only a map that is copyrighted by KEM Hospital Research Centre Pune and have submitted a permission letter under CC BY 4.0 license.
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Reviewer \#1: All comments have been addressed
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2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes
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3\. Has the statistical analysis been performed appropriately and rigorously?
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4\. Have the authors made all data underlying the findings in their manuscript fully available?
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